These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [Oral lisuride in Parkinson's disease]. Obeso JA; Luquin MR; Martínez Lage JM Med Clin (Barc); 1985 Sep; 85(8):307-12. PubMed ID: 4068822 [No Abstract] [Full Text] [Related]
9. A 6-month trial of pergolide mesylate in the treatment of idiopathic Parkinson's disease. Klawans HL; Tanner CM; Glatt S; Goetz CG Adv Neurol; 1983; 37():75-83. PubMed ID: 6344592 [No Abstract] [Full Text] [Related]
10. Chronic s.c. lisuride in Parkinson's disease--motor-performance and avoidance of psychiatric side effects. Bittkau S; Przuntek H J Neural Transm Suppl; 1988; 27():35-54. PubMed ID: 3165438 [TBL] [Abstract][Full Text] [Related]
11. Use of lisuride in advanced Parkinson's disease. Potent dopamine and serotonin agonist. Lieberman AN; Goldstein M; Neophytides A; Leibowitz M; Gopinathan G; Goodgold A; Pact V; Walker R N Y State J Med; 1981 Nov; 81(12):1751-5. PubMed ID: 6949052 [No Abstract] [Full Text] [Related]
12. Dopamine agonists as primary treatment in Parkinson's disease. Rinne UK Adv Neurol; 1987; 45():519-23. PubMed ID: 3103394 [No Abstract] [Full Text] [Related]
14. The use of pergolide and lisuride, two experimental dopamine agonists, in patients with advanced Parkinson disease. Lieberman AN; Leibowitz M; Gopinathan G; Walker R; Hiesiger E; Nelson J; Goldstein M Am J Med Sci; 1985 Sep; 290(3):102-6. PubMed ID: 4050844 [TBL] [Abstract][Full Text] [Related]
15. The use of lisuride in severe Parkinson's disease. Chin D; Yu YL; Huang CY Clin Exp Neurol; 1986; 22():63-9. PubMed ID: 3581512 [TBL] [Abstract][Full Text] [Related]